A clinico-epidemiological study of periorbital melanosis
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20172205Keywords:
Periorbital melanosis, Type, Grading, Life style habits, Comorbid conditionsAbstract
Background: Besides the common alterations related to the intrinsic and extrinsic aging processes, there is one that affects individuals of any age, both sexes, and all races the so called dark circles, periorbital darkening or periorbital melanosis. There is scarcity of data regarding the incidence and prevalence of periorbital melanosis due to its transitory nature and lack of reasonable etiological explanation. Aim: To assess the prevalence of periorbital melanosis and to study the epidemiological factors responsible for the occurrence of periorbital melanosis.
Methods: A single centred, cross-sectional, descriptive study was conducted in patients attending the skin OPD of our teaching hospital from Jan 2016 – Dec 2016. A total of 250 patients were included in our study. Patients with hyperpigmentation around the orbital area of all ages and both genders were included in the study. A careful physical examination to detect involvement of upper or lower or both eyelids and extension beyond the periorbital region, colour of hyperpigmented areas (light brown/dark brown/red/blue), presence of any dermatological disease or scar in periorbital region were assessed. A detailed history was taken including duration of the condition, family history, history of atopy or drug intake, associated faulty habit or lifestyle.
Results: Based on the type of POM, vascular POM (44%) was found to be the most common type among our patients followed by constitutional (33.2%), post-inflammatory (13.6%) and shadow type (9.2%). Among the various factors for POM watching TV for more than 8 hours/day, usage of spectacles, sleeping habit of less than 6 hours/day, habit of regularly rubbing the eye, family history of POM, associated systemic disease like anaemia and irregular menstruation and associated skin lesion like atopic dermatitis had shown a strong association (odds ratio >0.8) in the development of POM.
Conclusions: It is very much essential to classify and grade the peri-orbital melanosis and to determine the causative factors which would help us to intervene earlier and that would result in a better prognosis.
Metrics
References
Koblenzer CS. Psychosocial aspects of beauty: how and why to look good. Clin Dermatol. 2003;21:473–475.
Yaar M, Gilchrest BA. Skin aging: postulated mechanisms and consequent changes in structure and function. Clin Geriatr Med. 2001;17:617–30.
Malakar S, Lahiri K, Banerjee U, Mondal S, Sarangi S. Periorbitalmelanosis is an extension of pigmentary demarcation line-F on face. Indian J Dermatol Venereol Leprol. 2007;73:323–5.
Watanabe S, Nakai K, Ohnishi T. Condition known as ‘dark rings under the eyes’ in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser. Dermatol Surg. 2006;32:785–9.
Hunzinker N. Apropos of familial hyperpigmentation of the eyelid. J Genet Hum. 1962;11:16–21.
Goodman RM, Belcher RW. Periorbital hyperpigmentation. An overlooked genetic disorder of pigmentation. Arch Dermatol. 1969;100:169–74.
Huang YL, Chang SL, Ma L. Clinical analysis and classification of dark eye circle. Int J Dermatol. 2014;53(2):164–70.
Lupo ML, Cohen JL, Rendon MI. Novel eye cream containing a mixture of human growth factors and cytokines for periorbital skin rejuvenation. J Drugs Dermatol. 2007;6:725–9.
Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22:443–7.
Friedmann DP, Goldman MP. Dark circles: etiology and management options. Clin Plast Surg. 2015;42(1):33–50.
Paraskevas LR, Halpern AC, Marghoob AA. Utility of the Wood’s light: five cases from a pigmented lesion clinic. Br J Dermatol. 2005;152(5):1039–44.
Stanganelli I, Elston DM, Pizzichetta MA, Talamini R. Dermoscopy. Available at: http://emedicine. medscape.com/article/1130783-overview. Accessed 10 January 2016.
Freitag FM, Cestari TF. What causes dark circles under the eyes? J Cosmet Dermatol. 2007;6(3):211-5.
Ranu H, Thng S, Goh BK. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification. Dermatol Surg. 2011;37(9):1297–303.
Sheth PB, Shah HA, Dave JN. Periorbital hyperpigmentation: a study of its prevalence, common causative factors and its association with personal habits and other disorders. Indian J Dermatol. 2014;59(2):151–7.
Strachan T, Read AP. Genes in pedigrees and population. In: Strachan T, editor. Human Molecular Genetics. 3rd edition. New York: Garland Science; 2003: 106-107.
Gathers RC. Periorbitalhypermelanosis. In: Paul KA, editor. Dermatology for Skin of Color. 1st edition. New York: McGraw Hill; 2009: 341-343.
Gendler EC. Treatment of periorbital hyperpigmentation. Aesthet Surg J. 2005;25:618-24.
